Suppression of LH during ovarian stimulation:: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH

被引:113
作者
Balasch, J
Vidal, E
Peñarrubia, J
Casamitjana, R
Carmona, F
Creus, M
Fábregues, F
Vanrell, JA
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Inst Clin Gynecol Obstet & Neonatol, IDIBAPS, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Fac Med, Hormonal Lab, E-08036 Barcelona, Spain
关键词
assisted reproduction; early pregnancy loss; FSH; LH; ovarian stimulation;
D O I
10.1093/humrep/16.8.1636
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: It has been recently suggested that gonadotrophin-releasing hormone agonist down-regulation in some normogonadotrophic women may result in profound suppression of LH concentrations, impairing adequate oestradiol synthesis and IVF and pregnancy outcome. The aims of this study, where receiver-operating characteristic (ROC) analysis was used, were: (i) to assess the usefulness of serum LH measurement on stimulation day 7 (S7) as a predictor of ovarian response, IVF outcome, implantation, and the outcome of pregnancy in patients treated with recombinant FSH under pituitary suppression; and (ii) to define the best threshold value, if any, to discriminate between women with 'low' or 'normal' LH concentrations. METHODS: A total of 144 infertile women undergoing IVF/intracytoplasmic sperm injection (ICSI) treatment were included. Seventy-two consecutive patients having a positive pregnancy test (including 58 ongoing pregnancies and 14 early pregnancy losses) were initially selected. As a control non-pregnant group, the next non-conception IVF/ICSI cycle after each conceptual cycle in our assisted reproduction programme was used. RESULTS: The median and range of LH values in non-conception cycles, conception cycles, ongoing pregnancies, and early pregnancy losses, clearly overlapped. ROC analysis showed that serum LH concentration on S7 was unable to discriminate between conception and non-conception cycles (AUC(ROC) = 0.52; 95% CI: 0.44 to 0.61) or ongoing pregnancy versus early pregnancy loss groups (AUC(ROC) = 0.59; 95% CI: 0.46 to 0.70). To assess further the potential impact of suppressed concentrations of circulating LH during ovarian stimulation on the outcome of IVF/ICSI treatment, the three threshold values of mid-follicular serum LH proposed in the literature (<1, less than or equal to0.7, <0.5 IU/I) to discriminate between women with 'low' or 'normal' LH were applied to our study population. No significant differences were found with respect to ovarian response, IVF/ICSI outcome, implantation, and the outcome of pregnancy between 'low' and 'normal' S7 LH women as defined by those threshold values. CONCLUSIONS: Our results do not support the need for additional exogenous LH supplementation in down-regulated women receiving a recombinant FSH-only preparation.
引用
收藏
页码:1636 / 1643
页数:8
相关论文
共 32 条
[1]   Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients [J].
Balasch, J ;
Fabregues, F ;
Penarrubia, J ;
Creus, M ;
Vidal, R ;
Casamitjana, R ;
Manau, D ;
Vanrell, JA .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1998, 15 (09) :552-559
[2]  
BALASCH J, 1992, FERTIL STERIL, V58, P991
[3]   THE ROLE OF LUTEINIZING-HORMONE IN HUMAN FOLLICLE DEVELOPMENT AND OOCYTE FERTILITY - EVIDENCE FROM IN-VITRO FERTILIZATION IN A WOMAN WITH LONG-STANDING HYPOGONADOTROPIC HYPOGONADISM AND USING RECOMBINANT HUMAN FOLLICLE-STIMULATING-HORMONE [J].
BALASCH, J ;
MIRO, F ;
BURZACO, I ;
CASAMITJANA, R ;
CIVICO, S ;
BALLESCA, JL ;
PUERTO, B ;
VANRELL, JA .
HUMAN REPRODUCTION, 1995, 10 (07) :1678-1683
[4]   Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues [J].
Barbieri, RL ;
Hornstein, MD .
ENDOCRINE REVIEWS, 1999, 20 (03) :249-252
[5]   REEVALUATION OF THE ROLES OF LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING-HORMONE IN THE OVULATORY PROCESS [J].
CHAPPEL, SC ;
HOWLES, C .
HUMAN REPRODUCTION, 1991, 6 (09) :1206-1212
[6]  
CONN PM, 1991, NEW ENGL J MED, V324, P93
[7]   Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant follicle stimulating hormone-supplemented mouse preantral follicle culture [J].
Cortvrindt, R ;
Hu, Y ;
Smitz, J .
HUMAN REPRODUCTION, 1998, 13 (05) :1292-1302
[8]  
Daya S, 1998, OVULATION INDUCTION, P183
[9]   Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer.: Relationship to estradiol and progesterone [J].
Fábregues, F ;
Balasch, J ;
Manau, D ;
Creus, M ;
Jiménez, W ;
Carmona, F ;
Casamitjana, R ;
Vanrell, JA .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (07) :564-569
[10]   The role of luteinizing hormone in folliculogenesis and ovulation induction [J].
Filicori, M .
FERTILITY AND STERILITY, 1999, 71 (03) :405-414